Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age and older
Diagnosis of atrial fibrillation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights
Study Summary
This trial is testing a new 12-lead ECG system that is MRI-conditional and addresses the MRI-induced interference and safety issues.
Who is the study for?
This trial is for adults over 18 with atrial fibrillation who have health insurance coverage through the Ontario Health Insurance Plan. It's not suitable for those with certain metal implants, claustrophobia, pregnant women, people unstable in their blood circulation or those with a permanent pacemaker or ICD.Check my eligibility
What is being tested?
The study tests a new MRI-compatible 12-lead ECG monitoring device against the standard 3-lead system during cardiac MRI scans. The goal is to see if the new device can better detect heart issues without being affected by MRI interference.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring during an MRI scan, side effects are minimal but may include discomfort from lying still and anxiety within the confined space of an MRI machine.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have been diagnosed with atrial fibrillation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
absolute numbers and percentages
qualitatively comparison with a standard scale
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 12-Lead ECGExperimental Treatment1 Intervention
The study group patients will have MRI with 12-lead ECG monitoring device produced by a Massachusetts-based medical device company MiRTLE Medical
Group II: 3-lead ECG gating systemActive Control1 Intervention
the control group will have MRI with 3-lead ECG gating which is standard of care.
Find a Location
Who is running the clinical trial?
Dr. Graham WrightLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are afraid of being in small or enclosed spaces.I am 18 years old or older.You have a permanent pacemaker or ICD (implantable cardioverter defibrillator) in your body.I cannot undergo CMR due to health reasons.My blood pressure is not stable.I have been diagnosed with atrial fibrillation.You have a metal clip in your brain blood vessels or a clamp on your neck blood vessels.
Research Study Groups:
This trial has the following groups:- Group 1: 12-Lead ECG
- Group 2: 3-lead ECG gating system
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger